Paul B. Rosenberg
0000-0003-1106-4299
Publication & Citation Trends
Publications
317 total
Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) study.
Cited by 0
Semantic Scholar
Uncovering Lipid Biomarkers Linked to Methylphenidate Efficacy in Treating Apathy in Alzheimer's Disease: Insights from the ADMET 2 trial
Cited by 0
Semantic Scholar
Methylphenidate for Apathy in Alzheimer's Disease: Addressing Heterogeneity of Response, Safety Outcomes and Future Directions
Cited by 0
Semantic Scholar
Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2
Cited by 2
Semantic Scholar
Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study OA
Cited by 8
Semantic Scholar
Impact of motor dysfunction on neuropsychiatric symptom profile in patients with autopsy-confirmed Alzheimer’s disease
Cited by 2
Semantic Scholar
Correlation between changes in apathy and cognition in Alzheimer’s disease associated apathy: Analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2) OA
Cited by 0
Semantic Scholar
iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer’s disease OA
Cited by 18
Semantic Scholar
Clinical Manifestations. OA
Cited by 1
Semantic Scholar
Research Topics
Dementia and Cognitive Impairment Research
(146)
Alzheimer's disease research and treatments
(62)
Functional Brain Connectivity Studies
(27)
Schizophrenia research and treatment
(23)
Intensive Care Unit Cognitive Disorders
(23)
Affiliations
University of Notre Dame
Northwestern University
Scripps Research Institute
Kennedy Krieger Institute
Verizon (United States)